Last update 07 Jun 2025

LUCAR-20SD(Nanjing Legend Biotechnology)

Overview

Basic Info

Drug Type
Universal CAR-T
Synonyms
LUCAR 20SD, LUCAR-20SD, LUCAR20SD
Target
CD20
Action
inhibitors
Mechanism
CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors)
Therapeutic Areas
NeoplasmsImmune System DiseasesHemic and Lymphatic Diseases
Active Indication-
Inactive Indication
Follicular LymphomaMantle-Cell LymphomaSmall Lymphocytic Lymphoma
Originator Organization
Nanjing Legend Biotech Co., Ltd.Nanjing Legend Biotech Co., Ltd.
Active Organization-
Inactive Organization
Nanjing Legend Biotech Co., Ltd.Nanjing Legend Biotech Co., Ltd.
License Organization-
Drug Highest PhaseDiscontinuedPhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with LUCAR-20SD(Nanjing Legend Biotechnology)
NCT04176913
/ TerminatedPhase 1IIT
A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of LUCAR-20S in Patients With Relapsed/Refractory Diffuse Large B-Cell, Follicular, Mantle Cell or Small Lymphocytic Lymphoma
100 Clinical Results associated with LUCAR-20SD(Nanjing Legend Biotechnology)
Login to view more data
100 Translational Medicine associated with LUCAR-20SD(Nanjing Legend Biotechnology)
Login to view more data
100 Patents (Medical) associated with LUCAR-20SD(Nanjing Legend Biotechnology)
Login to view more data
100 Deals associated with LUCAR-20SD(Nanjing Legend Biotechnology)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Follicular LymphomaPhase 1
China
Nanjing Legend Biotech Co., Ltd.Nanjing Legend Biotech Co., Ltd.
01 Dec 2020
Mantle-Cell LymphomaPhase 1
China
Nanjing Legend Biotech Co., Ltd.Nanjing Legend Biotech Co., Ltd.
01 Dec 2020
Small Lymphocytic LymphomaPhase 1
China
Nanjing Legend Biotech Co., Ltd.Nanjing Legend Biotech Co., Ltd.
01 Dec 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free